TD SYNNEX (SNX) director Hume exercises 18,365 options and sells stock

Rhea-AI Filing Summary

TD SYNNEX director Richard T. Hume reported an option exercise and related share sales. On February 2, 2026, he exercised 18,365 employee stock options at an exercise price of $107.32 per share, receiving the same number of TD SYNNEX common shares.

That day he sold several blocks of common stock in open-market transactions under a Rule 10b5-1 trading plan adopted on July 14, 2025. Reported weighted-average sale prices included $157.66, $158.58, $159.64, $160.55, and $161.18 per share. Following these transactions, Hume directly owned 42,515 TD SYNNEX shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUME RICHARD T

(Last) (First) (Middle)

5350 TECH DATA DRIVE

(Street)

CLEARWATER FL 33760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/02/2026		M(1)		18,365	A	$107.32	65,880	D
Common Stock	02/02/2026		S(1)		216	D	$157.66(2)	65,664	D
Common Stock	02/02/2026		S(1)		236	D	$158.58(3)	65,428	D
Common Stock	02/02/2026		S(1)		527	D	$159.64(4)	64,901	D
Common Stock	02/02/2026		S(1)		17,093	D	$160.55(5)	47,808	D
Common Stock	02/02/2026		S(1)		5,293	D	$161.18(6)	42,515	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$107.32	02/02/2026		M(1)			18,365	(7)	10/05/2031	Common Stock	18,365	$0	0	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.

2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $157.115 to $157.995. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

3. Represents the weighted average sales price for a number of transactions effected at prices ranging from $158.365 to $158.88. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

4. Represents the weighted average sales price for a number of transactions effected at prices ranging from $159.07 to $159.955. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

5. Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.00 to $160.995. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

6. Represents the weighted average sales price for a number of transactions effected at prices ranging from $161.00 to $161.51. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

7. This stock option is fully vested.

Remarks:

	/s/ Cheryl Grant, attorney-in-fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TD SYNNEX (SNX) disclose for Richard T. Hume?

TD SYNNEX director Richard T. Hume exercised 18,365 employee stock options and sold common shares on February 2, 2026. The transactions converted options into stock and then sold portions of those shares in the open market, as reflected in his updated share holdings.

How many TD SYNNEX (SNX) options did Richard T. Hume exercise?

Richard T. Hume exercised 18,365 employee stock options on February 2, 2026. Each option entitled him to buy one TD SYNNEX common share at an exercise price of $107.32, resulting in 18,365 newly acquired shares before any subsequent sales that same day.

At what prices did Richard T. Hume sell TD SYNNEX (SNX) shares?

His reported TD SYNNEX share sales used weighted-average prices. Disclosed averages were $157.66, $158.58, $159.64, $160.55, and $161.18 per share, each representing multiple trades within a narrow price range, with detailed breakdowns available upon request from the company or SEC staff.

How many TD SYNNEX (SNX) shares does Richard T. Hume own after these trades?

After the February 2, 2026 transactions, Richard T. Hume directly owned 42,515 TD SYNNEX common shares. This figure reflects the 18,365-option exercise, followed by several open-market sales executed the same day under his pre-established Rule 10b5-1 trading plan.

Was the TD SYNNEX (SNX) insider sale under a Rule 10b5-1 plan?

Yes. The stock option exercises and related sales were carried out under a Rule 10b5-1 trading plan adopted by Richard T. Hume on July 14, 2025. Such plans pre-schedule trades, helping separate them from day-to-day discretionary trading decisions.

What does the Form 4 say about Richard T. Hume’s TD SYNNEX (SNX) stock options?

The Form 4 shows an employee stock option with an exercise price of $107.32 for 18,365 shares of TD SYNNEX common stock. The filing notes this option is fully vested, and following the February 2, 2026 exercise, no derivative securities remained beneficially owned.